+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Canada in Vitro Diagnostics Market Size, Share & Trends Analysis Report by Product (Instruments, Reagents, Services), Technique, Application, End-use, Test Location, Province with Growth Forecasts, 2025-2030- Product Image
Canada in Vitro Diagnostics Market Size, Share & Trends Analysis Report by Product (Instruments, Reagents, Services), Technique, Application, End-use, Test Location, Province with Growth Forecasts, 2025-2030- Product Image
New

Canada in Vitro Diagnostics Market Size, Share & Trends Analysis Report by Product (Instruments, Reagents, Services), Technique, Application, End-use, Test Location, Province with Growth Forecasts, 2025-2030

  • PDF Icon

    Report

  • 100 Pages
  • May 2025
  • Region: Canada
  • Grand View Research
  • ID: 5846832
Description Jump to:
The Canada in Vitro Diagnostics Market was valued at USD 8.05 billion in 2024, and is projected to reach USD 10.68 billion by 2030, rising at a CAGR of 4.80%. Increasing R&D for the development of the technologically advanced in vitro diagnostics (IVD) systems for laboratories & hospitals to provide efficient, accurate, and error-free diagnosis is expected to fuel market growth. Moreover, the outbreak of COVID-19 disease has increased the growth at a significant rate.

High susceptibility to infections among the geriatric population is anticipated to increase the demand for in vitro diagnostic testing in Canada over the forecast period. The geriatric population is more likely to suffer from COVID-19 due to decreased immune function. According to the government of Canada, there were around 353,000 deaths between March 2020 and mid-May 2021, and people aged 65 and above accounted for around 80% of those deaths.

The country’s leading causes of death include heart disorders, cancer, chronic lower respiratory diseases, cerebrovascular diseases, and diabetes. Heart diseases and cancer accounted for the majority of deaths in Canada. Moreover, death rates from other disorders such as chronic lower respiratory diseases and cirrhosis/chronic liver disease have increased in recent years. The increasing number of cases of diabetes in Canada is anticipated to fuel market growth, with more than 10% of the population currently diagnosed with diabetes.

Moreover, the technological advancements in IVD testing are also expected to boost market growth during the forecast period. For instance, in February 2021, Thermo Fisher Scientific received approval from Health Canada for Applied Biosystems TaqPath COVID-19 HT Kit. Moreover, in June 2020, F. Hoffmann-La Roche Ltd received authorization for the Elecsys Anti-SARS-CoV-2 serology test under Health Canada’s Interim Order to make it available for laboratories and healthcare professionals. The introduction of novel products is expected to drive growth.

Key players in the Canada IVD industry are investing to expand their range of testing by undertaking R&D initiatives for the development of kits that target emerging diseases or by entering into agreements with other key manufacturing companies. In addition, innovative product launch in the market is a result of increasing R&D efforts and partnership programs established by players. For instance, in May 2021, LaunchWorks, a CDMO in molecular diagnostics, and Canadienzyme, a biotech spin-off company by two McGill University scientists, collaborated to produce RT-qPCR Master Mix, RT-qPCR testing reagent. Such initiatives undertaken by key players are expected to propel the market growth in the country.

Canada In Vitro Diagnostics Market Report Highlights

  • The reagents segment dominated the market with the largest revenue share of 65.5% in 2024
  • The molecular diagnostics segment held the largest market share in 2024, attributed to its crucial role in accurately diagnosing a wide range of diseases.
  • The infectious disease segment accounted for the largest market share in 2024, attributed to the high prevalence of infectious diseases and the need for accurate and timely diagnostics.
  • The hospital segment held the largest share in 2024, owing to its pivotal role in patient care and diagnostics.
  • Ontario's in vitro diagnostics market captured the largest revenue share of 31.1% in 2024, fueled by the advanced healthcare infrastructure of the province and the high prevalence of chronic diseases such as cancer and diabetes.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listings for you to stay ahead of the curve

Why Should You Buy This Report?

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This product will be delivered within 2 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. Technique
1.2.3. Application
1.2.4. End Use
1.2.5. Test Location
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Canada In Vitro Diagnostics Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Business Environment Analysis
3.3.1. Industry Analysis - Porter’s Five Forces Analysis
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTLE Analysis
Chapter 4. Canada In Vitro Diagnostics Market: Product Business Analysis
4.1. Product Market Share, 2024 & 2030
4.2. Product Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, By Product, 2018 to 2030 (USD Million)
4.4. Instruments
4.4.1. Instruments Market, 2018-2030 (USD Million)
4.5. Reagents
4.5.1. Reagents Market, 2018-2030 (USD Million)
4.6. Services
4.6.1. Services Market, 2018-2030 (USD Million)
Chapter 5. Canada In Vitro Diagnostics Market: Technique Business Analysis
5.1. Technique Market Share, 2024 & 2030
5.2. Technique Segment Dashboard
5.3. Market Size & Forecasts and Trend Analysis, By Technique, 2018 to 2030 (USD Million)
5.4. Immunoassay
5.4.1. Immunoassay Market, 2018-2030 (USD Million)
5.4.2. Instruments
5.4.2.1. Instruments Market For Immunoassay Estimates And Forecast, 2018-2030 (USD Million)
5.4.3. Reagents
5.4.3.1. Reagents Market For Immunoassay Estimates And Forecast, 2018-2030 (USD Million)
5.4.4. Services
5.4.4.1. Services Market For Immunoassay Estimates And Forecast, 2018-2030 (USD Million)
5.5. Hematology
5.5.1. Hematology Market, 2018-2030 (USD Million)
5.5.2. Instruments
5.5.2.1. Instruments Market For Hematology Estimates And Forecast, 2018-2030 (USD Million)
5.5.3. Reagents
5.5.3.1. Reagents Market For Hematology Estimates And Forecast, 2018-2030 (USD Million)
5.5.4. Services
5.5.4.1. Services Market For Hematology Estimates And Forecast, 2018-2030 (USD Million)
5.6. Clinical Chemistry
5.6.1. Clinical Chemistry Market, 2018-2030 (USD Million)
5.6.2. Instruments
5.6.2.1. Instruments Market For Hematology Estimates And Forecast, 2018-2030 (USD Million)
5.6.3. Reagents
5.6.3.1. Reagents Market For Hematology Estimates And Forecast, 2018-2030 (USD Million)
5.6.4. Services
5.6.4.1. Services Market For Hematology Estimates And Forecast, 2018-2030 (USD Million)
5.7. Molecular Diagnostics
5.7.1. Molecular Diagnostics Market, 2018-2030 (USD Million)
5.7.2. Instruments
5.7.2.1. Instruments Market For Hematology Estimates And Forecast, 2018-2030 (USD Million)
5.7.3. Reagents
5.7.3.1. Reagents Market For Hematology Estimates And Forecast, 2018-2030 (USD Million)
5.7.4. Services
5.7.4.1. Services Market For Hematology Estimates And Forecast, 2018-2030 (USD Million)
5.8. Coagulation
5.8.1. Coagulation Market, 2018-2030 (USD Million)
5.8.2. Instruments
5.8.2.1. Instruments Market For Hematology Estimates And Forecast, 2018-2030 (USD Million)
5.8.3. Reagents
5.8.3.1. Reagents Market For Hematology Estimates And Forecast, 2018-2030 (USD Million)
5.8.4. Services
5.8.4.1. Services Market For Hematology Estimates And Forecast, 2018-2030 (USD Million)
5.9. Microbiology
5.9.1. Microbiology Market, 2018-2030 (USD Million)
5.9.2. Instruments
5.9.2.1. Instruments Market For Hematology Estimates And Forecast, 2018-2030 (USD Million)
5.9.3. Reagents
5.9.3.1. Reagents Market For Hematology Estimates And Forecast, 2018-2030 (USD Million)
5.9.4. Services
5.9.4.1. Services Market For Hematology Estimates And Forecast, 2018-2030 (USD Million)
5.10. Others
5.10.1. Others Market, 2018-2030 (USD Million)
5.10.2. Instruments
5.10.2.1. Instruments Market For Hematology Estimates And Forecast, 2018-2030 (USD Million)
5.10.3. Reagents
5.10.3.1. Reagents Market For Hematology Estimates And Forecast, 2018-2030 (USD Million)
5.10.4. Services
5.10.4.1. Services Market For Hematology Estimates And Forecast, 2018-2030 (USD Million)
Chapter 6. Canada In Vitro Diagnostics Market: Application Business Analysis
6.1. Application Market Share, 2024 & 2030
6.2. Application Segment Dashboard
6.3. Market Size & Forecasts and Trend Analysis, By Application, 2018 to 2030 (USD Million)
6.4. Infectious Diseases
6.4.1. Infectious Diseases Market, 2018-2030 (USD Million)
6.5. Diabetes
6.5.1. Diabetes Market, 2018-2030 (USD Million)
6.6. Oncology
6.6.1. Oncology Market, 2018-2030 (USD Million)
6.7. Cardiology
6.7.1. Cardiology Market, 2018-2030 (USD Million)
6.8. Nephrology
6.8.1. Nephrology Market, 2018-2030 (USD Million)
6.9. Autoimmune Diseases
6.9.1. Autoimmune Diseases Market, 2018-2030 (USD Million)
6.10. Drug Testing
6.10.1. Drug Testing Market, 2018-2030 (USD Million)
6.11. Other Applications
6.11.1. Other Applications Market, 2018-2030 (USD Million)
Chapter 7. Canada In Vitro Diagnostics Market: End Use Business Analysis
7.1. End Use Market Share, 2024 & 2030
7.2. End Use Segment Dashboard
7.3. Market Size & Forecasts and Trend Analysis, By End Use, 2018 to 2030 (USD Million)
7.4. Hospitals
7.4.1. Hospitals Market, 2018-2030 (USD Million)
7.5. Primary Care
7.5.1. Primary Care Market, 2018-2030 (USD Million)
7.6. Laboratories
7.6.1. Laboratories Market, 2018-2030 (USD Million)
7.7. Home Care
7.7.1. Home Care Market, 2018-2030 (USD Million)
7.8. Others
7.8.1. Others Market, 2018-2030 (USD Million)
Chapter 8. Canada In Vitro Diagnostics Market: Test Location Business Analysis
8.1. Test Location Market Share, 2024 & 2030
8.2. Test Location Segment Dashboard
8.3. Market Size & Forecasts and Trend Analysis, By Test Location, 2018 to 2030 (USD Million)
8.4. Point of Care
8.4.1. Point of Care Market, 2018-2030 (USD Million)
8.5. Home Care
8.5.1. Home Care Market, 2018-2030 (USD Million)
8.6. Others
8.6.1. Others Market, 2018-2030 (USD Million)
Chapter 9. Canada In Vitro Diagnostics Market: Province Estimates & Trend Analysis
9.1. Province Market Share Analysis, 2024 & 2030
9.2. Province Market Dashboard
9.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030
9.4. Canada
9.4.1. Canada In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
9.4.2. Ontario
9.4.2.1. Key Country Dynamic
9.4.2.2. Regulatory Framework
9.4.2.3. Competitive Insights
9.4.2.4. Ontario In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
9.4.3. Quebec
9.4.3.1. Key Country Dynamic
9.4.3.2. Regulatory Framework
9.4.3.3. Competitive Insights
9.4.3.4. Quebec In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
9.4.4. West Canada
9.4.4.1. Key Country Dynamic
9.4.4.2. Regulatory Framework
9.4.4.3. Competitive Insights
9.4.4.4. West Canada In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
9.4.4.4.1.Alberta
9.4.4.4.1.1. Key Country Dynamic
9.4.4.4.1.2. Regulatory Framework
9.4.4.4.1.3. Competitive Insights
9.4.4.4.1.4. Alberta In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
9.4.4.4.2.Saskatchewan
9.4.4.4.2.1. Key Country Dynamic
9.4.4.4.2.2. Regulatory Framework
9.4.4.4.2.3. Competitive Insights
9.4.4.4.2.4. Saskatchewan In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
9.4.4.4.3.Manitoba
9.4.4.4.3.1. Key Country Dynamic
9.4.4.4.3.2. Regulatory Framework
9.4.4.4.3.3. Competitive Insights
9.4.4.4.3.4. Manitoba In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
9.4.4.4.4.British Columbia
9.4.4.4.4.1. Key Country Dynamic
9.4.4.4.4.2. Regulatory Framework
9.4.4.4.4.3. Competitive Insights
9.4.4.4.4.4. British Columbia In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
9.4.5. East Canada
9.4.5.1. Key Country Dynamic
9.4.5.2. Regulatory Framework
9.4.5.3. Competitive Insights
9.4.5.4. East Canada In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
9.4.5.5. Nova Scotia
9.4.5.5.1.1. Regulatory Framework
9.4.5.5.1.2. Competitive Insights
9.4.5.5.1.3. Nova Scotia In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
9.4.5.6. Prince Edward Island
9.4.5.6.1.1. Regulatory Framework
9.4.5.6.1.2. Competitive Insights
9.4.5.6.1.3. Prince Edward Island In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
9.4.5.7. New Brunswick
9.4.5.7.1.1. Regulatory Framework
9.4.5.7.1.2. Competitive Insights
9.4.5.7.1.3. New Brunswick In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
9.4.5.8. Newfoundland and Labrador
9.4.5.8.1.1. Regulatory Framework
9.4.5.8.1.2. Competitive Insights
9.4.5.8.1.3. Newfoundland and Labrador In Vitro Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 10. Competitive Landscape
10.1. Participant Overview
10.2. Company Market Position Analysis
10.3. Company Categorization
10.4. Strategy Mapping
10.5. Company Profiles/Listing
10.5.1. Abbott
10.5.1.1. Overview
10.5.1.2. Financial Performance
10.5.1.3. Product Benchmarking
10.5.1.4. Strategic Initiatives
10.5.2. bioMérieux SA
10.5.2.1. Overview
10.5.2.2. Financial Performance
10.5.2.3. Product Benchmarking
10.5.2.4. Strategic Initiatives
10.5.3. Bio-Rad Laboratories, Inc.
10.5.3.1. Overview
10.5.3.2. Financial Performance
10.5.3.3. Product Benchmarking
10.5.3.4. Strategic Initiatives
10.5.4. Siemens Healthineers AG
10.5.4.1. Overview
10.5.4.2. Financial Performance
10.5.4.3. Product Benchmarking
10.5.4.4. Strategic Initiatives
10.5.5. QIAGEN
10.5.5.1. Overview
10.5.5.2. Financial Performance
10.5.5.3. Product Benchmarking
10.5.5.4. Strategic Initiatives
10.5.6. QuidelOrtho Corporation
10.5.6.1. Overview
10.5.6.2. Financial Performance
10.5.6.3. Product Benchmarking
10.5.6.4. Strategic Initiatives
10.5.7. F. Hoffmann-La Roche Ltd
10.5.7.1. Overview
10.5.7.2. Financial Performance
10.5.7.3. Product Benchmarking
10.5.7.4. Strategic Initiatives
10.5.8. BD
10.5.8.1. Overview
10.5.8.2. Financial Performance
10.5.8.3. Product Benchmarking
10.5.8.4. Strategic Initiatives
10.5.9. Danaher
10.5.9.1. Overview
10.5.9.2. Financial Performance
10.5.9.3. Product Benchmarking
10.5.9.4. Strategic Initiatives
10.5.10. Agilent Technologies, Inc.
10.5.10.1. Overview
10.5.10.2. Financial Performance
10.5.10.3. Product Benchmarking
10.5.10.4. Strategic Initiatives
List of Tables
Table 1. List of Secondary Sources
Table 2. List of Abbreviations
Table 3. Canada In Vitro Diagnostics Market, By Province, 2018-2030 (USD Million)
Table 4. Canada In Vitro Diagnostics Market, By Product, 2018-2030 (USD Million)
Table 5. Canada In Vitro Diagnostics Market, By Technique, 2018-2030 (USD Million)
Table 6. Canada In Vitro Diagnostics Market, By Application, 2018-2030 (USD Million)
Table 7. Canada In Vitro Diagnostics Market, By End Use, 2018-2030 (USD Million)
Table 8. Canada In Vitro Diagnostics Market, By Test Location, 2018-2030 (USD Million)
Table 9. Ontario In Vitro Diagnostics Market, By Product, 2018-2030 (USD Million)
Table 10. Ontario In Vitro Diagnostics Market, By Technique, 2018-2030 (USD Million)
Table 11. Ontario In Vitro Diagnostics Market, By Application, 2018-2030 (USD Million)
Table 12. Ontario In Vitro Diagnostics Market, By End Use, 2018-2030 (USD Million)
Table 13. Ontario In Vitro Diagnostics Market, By Test Location, 2018-2030 (USD Million)
Table 14. Quebec In Vitro Diagnostics Market, By Product, 2018-2030 (USD Million)
Table 15. Quebec In Vitro Diagnostics Market, By Technique, 2018-2030 (USD Million)
Table 16. Quebec In Vitro Diagnostics Market, By Application, 2018-2030 (USD Million)
Table 17. Quebec In Vitro Diagnostics Market, By End Use, 2018-2030 (USD Million)
Table 18. Quebec In Vitro Diagnostics Market, By Test Location, 2018-2030 (USD Million)
Table 19. West Canada In Vitro Diagnostics Market, By Product, 2018-2030 (USD Million)
Table 20. West Canada In Vitro Diagnostics Market, By Technique, 2018-2030 (USD Million)
Table 21. West Canada In Vitro Diagnostics Market, By Application, 2018-2030 (USD Million)
Table 22. West Canada In Vitro Diagnostics Market, By End Use, 2018-2030 (USD Million)
Table 23. West Canada In Vitro Diagnostics Market, By Test Location, 2018-2030 (USD Million)
Table 24. Alberta In Vitro Diagnostics Market, By Product, 2018-2030 (USD Million)
Table 25. Alberta In Vitro Diagnostics Market, By Technique, 2018-2030 (USD Million)
Table 26. Alberta In Vitro Diagnostics Market, By Application, 2018-2030 (USD Million)
Table 27. Alberta In Vitro Diagnostics Market, By End Use, 2018-2030 (USD Million)
Table 28. Alberta In Vitro Diagnostics Market, By Test Location, 2018-2030 (USD Million)
Table 29. Saskatchewan In Vitro Diagnostics Market, By Product, 2018-2030 (USD Million)
Table 30. Saskatchewan In Vitro Diagnostics Market, By Technique, 2018-2030 (USD Million)
Table 31. Saskatchewan In Vitro Diagnostics Market, By Application, 2018-2030 (USD Million)
Table 32. Saskatchewan In Vitro Diagnostics Market, By End Use, 2018-2030 (USD Million)
Table 33. Saskatchewan In Vitro Diagnostics Market, By Test Location, 2018-2030 (USD Million)
Table 34. Manitoba In Vitro Diagnostics Market, By Product, 2018-2030 (USD Million)
Table 35. Manitoba In Vitro Diagnostics Market, By Technique, 2018-2030 (USD Million)
Table 36. Manitoba In Vitro Diagnostics Market, By Application, 2018-2030 (USD Million)
Table 37. Manitoba In Vitro Diagnostics Market, By End Use, 2018-2030 (USD Million)
Table 38. Manitoba In Vitro Diagnostics Market, By Test Location, 2018-2030 (USD Million)
Table 39. British Columbia In Vitro Diagnostics Market, By Product, 2018-2030 (USD Million)
Table 40. British Columbia In Vitro Diagnostics Market, By Technique, 2018-2030 (USD Million)
Table 41. British Columbia In Vitro Diagnostics Market, By Application, 2018-2030 (USD Million)
Table 42. British Columbia In Vitro Diagnostics Market, By End Use, 2018-2030 (USD Million)
Table 43. British Columbia In Vitro Diagnostics Market, By Test Location, 2018-2030 (USD Million)
Table 44. East Canada In Vitro Diagnostics Market, By Product, 2018-2030 (USD Million)
Table 45. East Canada In Vitro Diagnostics Market, By Technique, 2018-2030 (USD Million)
Table 46. East Canada In Vitro Diagnostics Market, By Application, 2018-2030 (USD Million)
Table 47. East Canada In Vitro Diagnostics Market, By End Use, 2018-2030 (USD Million)
Table 48. East Canada In Vitro Diagnostics Market, By Test Location, 2018-2030 (USD Million)
Table 49. Nova Scotia In Vitro Diagnostics Market, By Product, 2018-2030 (USD Million)
Table 50. Nova Scotia In Vitro Diagnostics Market, By Technique, 2018-2030 (USD Million)
Table 51. Nova Scotia In Vitro Diagnostics Market, By Application, 2018-2030 (USD Million)
Table 52. Nova Scotia In Vitro Diagnostics Market, By End Use, 2018-2030 (USD Million)
Table 53. Nova Scotia In Vitro Diagnostics Market, By Test Location, 2018-2030 (USD Million)
Table 54. Prince Edward Island In Vitro Diagnostics Market, By Product, 2018-2030 (USD Million)
Table 55. Prince Edward Island In Vitro Diagnostics Market, By Technique, 2018-2030 (USD Million)
Table 56. Prince Edward Island In Vitro Diagnostics Market, By Application, 2018-2030 (USD Million)
Table 57. Prince Edward Island In Vitro Diagnostics Market, By End Use, 2018-2030 (USD Million)
Table 58. Prince Edward Island In Vitro Diagnostics Market, By Test Location, 2018-2030 (USD Million)
Table 59. New Brunswick In Vitro Diagnostics Market, By Product, 2018-2030 (USD Million)
Table 60. New Brunswick In Vitro Diagnostics Market, By Technique, 2018-2030 (USD Million)
Table 61. New Brunswick In Vitro Diagnostics Market, By Application, 2018-2030 (USD Million)
Table 62. New Brunswick In Vitro Diagnostics Market, By End Use, 2018-2030 (USD Million)
Table 63. New Brunswick In Vitro Diagnostics Market, By Test Location, 2018-2030 (USD Million)
Table 64. Newfoundland and Labrador In Vitro Diagnostics Market, By Product, 2018-2030 (USD Million)
Table 65. Newfoundland and Labrador In Vitro Diagnostics Market, By Technique, 2018-2030 (USD Million)
Table 66. Newfoundland and Labrador In Vitro Diagnostics Market, By Application, 2018-2030 (USD Million)
Table 67. Newfoundland and Labrador In Vitro Diagnostics Market, By End Use, 2018-2030 (USD Million)
Table 68. Newfoundland and Labrador In Vitro Diagnostics Market, By Test Location, 2018-2030 (USD Million)
List of Figures
Figure 1 Canada In Vitro Diagnostics Market Segmentation
Figure 2 Market Research Process
Figure 3 Data Triangulation Techniques
Figure 4 Primary Research Pattern
Figure 5 Market Research Approaches
Figure 6 Value-Chain-Based Sizing & Forecasting
Figure 7 Market Formulation & Validation
Figure 8 Market Snapshot
Figure 9 Product and Technique Outlook (USD Million)
Figure 10 Competitive Landscape
Figure 11 Canada In Vitro Diagnostics Market Dynamics
Figure 12 Canada In Vitro Diagnostics Market: Porter’s Five Forces analysis
Figure 13 Canada In Vitro Diagnostics Market: PESTLE Analysis
Figure 14 Canada In Vitro Diagnostics Market: Product Segment Dashboard
Figure 15 Canada In Vitro Diagnostics Market: Product Market Share Analysis, 2024 & 2030
Figure 16 Instruments Market, 2018-2030 (USD Million)
Figure 17 Reagents Market, 2018-2030 (USD Million)
Figure 18 Services Market, 2018-2030 (USD Million)
Figure 19 Canada In Vitro Diagnostics Market: Technique Segment Dashboard
Figure 20 Canada In Vitro Diagnostics Market: Technique Market Share Analysis, 2024 & 2030
Figure 21 Immunoassay Market, 2018-2030 (USD Million)
Figure 22 Instruments Market For Immunoassay Estimates and Forecast, 2018-2030 (USD Million)
Figure 23 Reagents Market For Immunoassay Estimates and Forecast, 2018-2030 (USD Million)
Figure 24 Services Market For Immunoassay Estimates and Forecast, 2018-2030 (USD Million)
Figure 25 Hematology Market, 2018-2030 (USD Million)
Figure 26 Instruments Market For Immunoassay Estimates and Forecast, 2018-2030 (USD Million)
Figure 27 Reagents Market For Immunoassay Estimates and Forecast, 2018-2030 (USD Million)
Figure 28 Services Market For Immunoassay Estimates and Forecast, 2018-2030 (USD Million)
Figure 29 Clinical Chemistry Market, 2018-2030 (USD Million)
Figure 30 Instruments Market For Immunoassay Estimates and Forecast, 2018-2030 (USD Million)
Figure 31 Reagents Market For Immunoassay Estimates and Forecast, 2018-2030 (USD Million)
Figure 32 Services Market For Immunoassay Estimates and Forecast, 2018-2030 (USD Million)
Figure 33 Molecular Diagnostics Market, 2018-2030 (USD Million)
Figure 34 Instruments Market For Immunoassay Estimates and Forecast, 2018-2030 (USD Million)
Figure 35 Reagents Market For Immunoassay Estimates and Forecast, 2018-2030 (USD Million)
Figure 36 Services Market For Immunoassay Estimates and Forecast, 2018-2030 (USD Million)
Figure 37 Coagulation Market, 2018-2030 (USD Million)
Figure 38 Instruments Market For Immunoassay Estimates and Forecast, 2018-2030 (USD Million)
Figure 39 Reagents Market For Immunoassay Estimates and Forecast, 2018-2030 (USD Million)
Figure 40 Services Market For Immunoassay Estimates and Forecast, 2018-2030 (USD Million)
Figure 41 Microbiology Market, 2018-2030 (USD Million)
Figure 42 Instruments Market For Immunoassay Estimates and Forecast, 2018-2030 (USD Million)
Figure 43 Reagents Market For Immunoassay Estimates and Forecast, 2018-2030 (USD Million)
Figure 44 Services Market For Immunoassay Estimates and Forecast, 2018-2030 (USD Million)
Figure 45 Others Market, 2018-2030 (USD Million)
Figure 46 Instruments Market For Immunoassay Estimates and Forecast, 2018-2030 (USD Million)
Figure 47 Reagents Market For Immunoassay Estimates and Forecast, 2018-2030 (USD Million)
Figure 48 Services Market For Immunoassay Estimates and Forecast, 2018-2030 (USD Million)
Figure 49 Canada In Vitro Diagnostics Market: Application Segment Dashboard
Figure 50 Canada In Vitro Diagnostics Market: Application Market Share Analysis, 2024 & 2030
Figure 51 Infectious Diseases Market, 2018-2030 (USD Million)
Figure 52 Diabetes Market, 2018-2030 (USD Million)
Figure 53 Oncology Market, 2018-2030 (USD Million)
Figure 54 Cardiology Market, 2018-2030 (USD Million)
Figure 55 Nephrology Market, 2018-2030 (USD Million)
Figure 56 Autoimmune Diseases Market, 2018-2030 (USD Million)
Figure 57 Drug Testing Market, 2018-2030 (USD Million)
Figure 58 Other applications Market, 2018-2030 (USD Million)
Figure 59Canada In Vitro Diagnostics Market: End Use Segment Dashboard
Figure 60 Canada In Vitro Diagnostics Market: End Use Market Share Analysis, 2024 & 2030
Figure 61 Hospitals Market, 2018-2030 (USD Million)
Figure 62 Primary Care Market, 2018-2030 (USD Million)
Figure 63 Laboratories Market, 2018-2030 (USD Million)
Figure 64 Home Care Market, 2018-2030 (USD Million)
Figure 65 Others Market, 2018-2030 (USD Million)
Figure 66 Canada In Vitro Diagnostics Market: Test Location Segment Dashboard
Figure 67 Canada In Vitro Diagnostics Market: Test Location Market Share Analysis, 2024 & 2030
Figure 68 Point of Care Market, 2018-2030 (USD Million)
Figure 69 Home Care Market, 2018-2030 (USD Million)
Figure 70 Others Market, 2018-2030 (USD Million)
Figure 71 Canada In Vitro Diagnostics Market Revenue, By Province
Figure 72 Province Outlook and Key Takeaways
Figure 73 Canada In Vitro Diagnostics Market: Province Movement Analysis
Figure 74 Canada In Vitro Diagnostics Market, 2018-2030 (USD Million)
Figure 75 Ontario Country Dynamics
Figure 76 Ontario In Vitro Diagnostics Market, 2018-2030 (USD Million)
Figure 77 Quebec Country Dynamics
Figure 78 Quebec In Vitro Diagnostics Market, 2018-2030 (USD Million)
Figure 79 West Canada Country Dynamics
Figure 80 West Canada In Vitro Diagnostics Market, 2018-2030 (USD Million)
Figure 81 Alberta Country Dynamics
Figure 82 Alberta In Vitro Diagnostics Market, 2018-2030 (USD Million)
Figure 83 Saskatchewan Country Dynamics
Figure 84 Saskatchewan In Vitro Diagnostics Market, 2018-2030 (USD Million)
Figure 85 Manitoba Country Dynamics
Figure 86 Manitoba In Vitro Diagnostics Market, 2018-2030 (USD Million)
Figure 87 British Columbia Country Dynamics
Figure 88 British Columbia In Vitro Diagnostics Market, 2018-2030 (USD Million)
Figure 89 East Canada Country Dynamics
Figure 90 East Canada Canada In Vitro Diagnostics Market, 2018-2030 (USD Million)
Figure 91 Nova Scotia Country Dynamics
Figure 92 Nova Scotia In Vitro Diagnostics Market, 2018-2030 (USD Million)
Figure 93 Prince Edward Island Country Dynamics
Figure 94 Prince Edward Island In Vitro Diagnostics Market, 2018-2030 (USD Million)
Figure 95 New Brunswick Country Dynamics
Figure 96 New Brunswick In Vitro Diagnostics Market, 2018-2030 (USD Million)
Figure 97 Newfoundland and Labrador Country Dynamics
Figure 98 Newfoundland and Labrador In Vitro Diagnostics Market, 2018-2030 (USD Million)
Figure 99 Company Categorization
Figure 100 Company Market Position Analysis
Figure 101 Strategic Framework

Companies Mentioned

The major companies featured in this Canada in Vitro Diagnostics market report include:
  • Abbott
  • bioMérieux SA
  • Bio-Rad Laboratories, Inc.
  • Siemens Healthineers AG
  • QIAGEN
  • QuidelOrtho Corporation
  • F. Hoffmann-La Roche Ltd
  • BD
  • Danaher
  • Agilent Technologies, Inc.

Table Information

Report AttributeDetails
No. of Pages100
PublishedMay 2025
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 8.05 Billion
Forecasted Market Value ( USD ) by 2030 $ 10.68 Billion
Compound Annual Growth Rate4.8%
Regions CoveredCanada
No. of Companies Mentioned11

Related Topics

Related Reports

In Vitro Diagnostics Market, Industry Trends and Global Forecasts to 2035: Distribution by Test Type, Type of Offering, Type of Technology, Therapeutic Area, End Users and Geographical Regions - Product Image

In Vitro Diagnostics Market, Industry Trends and Global Forecasts to 2035: Distribution by Test Type, Type of Offering, Type of Technology, Therapeutic Area, End Users and Geographical Regions

  • Report
  • 188 Pages
  • Global
From
In-Vitro Diagnostic Market - North America and Country Analysis: Focus on Product, Test Type, Application, End User, and Country Analysis - Analysis and Forecast, 2025-2035 - Product Image

In-Vitro Diagnostic Market - North America and Country Analysis: Focus on Product, Test Type, Application, End User, and Country Analysis - Analysis and Forecast, 2025-2035

  • Report
  • North America
From
Introduction to the In-Vitro Diagnostic Regulation (IVDR) Training Course (November 4-5, 2025) - Product Image

Introduction to the In-Vitro Diagnostic Regulation (IVDR) Training Course (November 4-5, 2025)

  • Training
  • 2 Days
  • Global
In Vitro Diagnostics Market Size, Share & Trends Analysis Report by Product (Instruments, Reagents), Test Location, End Use (Hospitals, Laboratory), Application, Technology (Molecular Diagnostics), and Region with Growth Forecasts, 2025-2030 - Product Image

In Vitro Diagnostics Market Size, Share & Trends Analysis Report by Product (Instruments, Reagents), Test Location, End Use (Hospitals, Laboratory), Application, Technology (Molecular Diagnostics), and Region with Growth Forecasts, 2025-2030

  • Report
  • 320 Pages
  • Global
From
In-Vitro Diagnostics Quality Control Market by Product Type, Technology, Application, End User - Global Forecast to 2030 - Product Image

In-Vitro Diagnostics Quality Control Market by Product Type, Technology, Application, End User - Global Forecast to 2030

  • Report
  • 191 Pages
  • Global
From

About the In Vitro Diagnostics Market

In Vitro Diagnostics (IVD) is a medical technology used to diagnose diseases and conditions through the analysis of bodily fluids and tissues. It is used to detect, diagnose, and monitor diseases, as well as to assess the effectiveness of treatments. IVD tests are performed in laboratories, hospitals, and other healthcare settings. IVD tests are used to detect a wide range of conditions, including infections, genetic disorders, and cancer. They can also be used to monitor the progress of a disease or to assess the effectiveness of a treatment. IVD tests are used to detect and measure the presence of specific molecules, such as proteins, hormones, and enzymes, in a sample. IVD tests are performed using a variety of technologies, including immunoassays, molecular diagnostics, and flow cytometry. These tests are used to diagnose a wide range of conditions, including infectious diseases, genetic disorders, and cancer. Some of the major companies in the IVD market include Abbott Laboratories, Becton Dickinson, Roche Diagnostics, Siemens Healthineers, and Thermo Fisher Scientific. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.